NCT03177096

Brief Summary

The implementation of a sensor of glycemia Enlite coupled with an insulin pump (Medtronic Minimed 640G) is a therapeutic option that Hospital of Mulhouse can propose to the children affected by type 1 diabetes. The glycemic rate detected by the sensor of continuous measure of the glycemia is visible in real time on the pump and then the rate can be normalized. The study will evaluate the impact of the continuous measurement of blood glucose on insulin pump on child quality of life with type 1 diabetes aged 2 to 13 years old.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 6, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2017

Completed
Last Updated

August 21, 2019

Status Verified

May 1, 2018

Enrollment Period

10 months

First QC Date

June 2, 2017

Last Update Submit

August 20, 2019

Conditions

Keywords

Type 1 diabetes children,School,Childcare facilities,Sensor

Outcome Measures

Primary Outcomes (1)

  • Evolution of Peds QL questionnaire results

    Questionnaire of quality of life (QL)

    Through study completion, an average of 10 months

Secondary Outcomes (1)

  • Evolution of WHO-5 and felt questionnaire

    through study completion, an average of 10 months

Study Arms (1)

Peds QL questionnaire and diabetes modulate

EXPERIMENTAL

Routine practice of a continuous measure sensor of the glycemia with insulin pump for children aged 2 to 13 years followed at Mulhouse Hospital for type 1 diabetes : 5 sessions after enrollment visit(V1) (1 session 2 months, 4 months, 6 months, 8 months and 10 months) This study will be proposed to patients treated for type 1 diabetes enrolled in kindergarten, primary school, attending a nursery or a childcare center (patient's participation = 10 months) and will evaluate the child quality of life and the parents and staffs in preschool and school felt too.

Behavioral: Peds QL questionnaire and diabetes modulateBehavioral: WHO-5 questionnaireBehavioral: Felt questionnaire

Interventions

Peds QL questionnaire and diabetes modulate is a pediatric questionnaire about quality of life - children's version and parents version : assessed in the 1st visit (enrollment visit) and after ten months ( V6 End of study)

Peds QL questionnaire and diabetes modulate

WHO-5 questionnaire is a questionnaire about quality of life : assessed in the 1st visit (enrollment visit) and after ten months (V6 End of Study) by the children

Peds QL questionnaire and diabetes modulate

Felt questionnaire completed by parents with regard to the welcome of their child in community and by the staffs in preschool, school or in out-of school center : assessed 2 months (V2) and ten months (V6 End of study) after enrollment visit

Peds QL questionnaire and diabetes modulate

Eligibility Criteria

Age2 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Enrollment between September 15 to November 15, 2016
  • Insulin-dependent Type 1 Diabetes with insulin pump
  • From 2 to 13 years old
  • Schooled to the nursery or primary school, seeing frequently a day-nursery or in an out-of-school center
  • Treated at the hospital of Mulhouse, France

You may not qualify if:

  • Opposition to study participation
  • Patients who don't need sensor of measure of the continuous glycemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GHRMSA

Mulhouse, 68100, France

Location

Related Publications (7)

  • Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, Maahs DM; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014 Sep;15 Suppl 20:102-14. doi: 10.1111/pedi.12190. No abstract available.

    PMID: 25182311BACKGROUND
  • Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther. 2014 Jun;16(6):338-47. doi: 10.1089/dia.2013.0327. Epub 2014 Jan 21.

    PMID: 24447074BACKGROUND
  • Conget I, Choudhary P, Olsen BS et al. Prevention of hypoglycaemia by the predictive low glucose management feature in a user evaluation study. abstract #865

    BACKGROUND
  • Choudhary P, Olsen BS, Conget I, Welsh JB, Vorrink L, Shin JJ. Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management. Diabetes Technol Ther. 2016 May;18(5):288-91. doi: 10.1089/dia.2015.0324. Epub 2016 Feb 23.

    PMID: 26907513BACKGROUND
  • Besbes H, Hammami S et al. SFP P-024 - Etude de la qualité de vie des enfants atteints de diabète de type 1 ; Archives de Pédiatrie Volume 21, Issue 5, Supplement 1, May 2014, Pages 734

    BACKGROUND
  • Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care. 2003 Mar;26(3):631-7. doi: 10.2337/diacare.26.3.631.

    PMID: 12610013BACKGROUND
  • Institut de Veille Sanitaire. Prévalence et incidence du diabète / Données épidémiologiques / Diabète / Maladies chroniques et traumatismes / Dossiers thématiques / Accueil

    BACKGROUND

Study Officials

  • Fatiha GUEMAZI-KHEFFI, MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2017

First Posted

June 6, 2017

Study Start

September 20, 2016

Primary Completion

July 12, 2017

Study Completion

July 12, 2017

Last Updated

August 21, 2019

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations